Sophia Bolhassan Email

VP, Corporate Affairs and Investor Relations . Oxford Biomedica

Current Roles

Employees:
855
Revenue:
$132.5M
About
Oxford BioMedica (OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. We have built a sector-leading lentiviral vector delivery platform, called LentiVector®, which we use to develop in vivo and ex vivo products both in-house and with partners. We have created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. We also have a number of partnerships, including with Novartis, Sanofi, GSK and Orchard Therapeutics, where we have long-term economic interests in other potential gene and cell therapy products. OXB is based across four locations in Oxfordshire, UK.
Oxford Biomedica Address
Windrush Court Transport way
null, null
UK
Oxford Biomedica Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.